Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Pharmaceutics, glass primary packaging: Stevanato Group doubles size of Mexico plant

300 jobs and 148 million pesos generated through allied industries.

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Stevanato Group, a leader in glass primary pharmaceutical packaging for injectables, headquartered in northern Italy, doubles the size of its manufacturing plant in Mexico, Cienega de Flores in Monterrey, in the state of Nuovo Leon. The Mexican plant, opened in 2008 to serve the needs of the American market, has doubled in size thanks to an investment of around €22 million, now measuring 12,000 square metres (indoor). The doubling in size of the plant will allow an increase in production that conforms to the highest international pharmaceutical primary packaging quality standards. Income generated for the local economy through allied industries stands at 148 million pesos, around €9 million, creating 300 skilled worker positions, 98% of whom are Mexican. All of these figures are set to increase significantly as the plant at Monterrey is one of the most advanced facilities in the world in terms of technology used in the production of glass containers for pharmaceutical use (vials, ampoules and cartridges).

What makes Stevanato Group unique in the global landscape is its production technology, having conceived and developed EZ-fillTM, a process that guarantees the sterilization of glass containers that, in this way, are delivered to pharmaceutical companies ready to fill. This system is a technology created and developed thanks to close collaboration between the Research and Development department, the Glass Division and the Engineering Division

The multinational that operates in 150 countries worldwide, counts 1,500 employees and an export share of 90%, ended 2012 with consolidated revenue of €208 million and a forecast for 2013 of €242 million. The expansion of the Mexican operation follows the start of work on the new production plant in China. Work began in November on the 30,000 square metre plot, being built to serve the rapidly developing Far East market, and the future plant will provide jobs for 250 staff.

The 2013-2016 industrial development plan anticipates a total investment of €140 million to support the organic growth. This will permit the optimization of processes and internal structures, the streamlining of the worldwide production process and the revision of technology and company procedures. The Engineering Division will also be of great importance in this phase of development, paying great attention to technological innovation, something that has always played a key role in setting Stevanato Group apart from the competition. It will aim to increase market share in areas of greatest expansion (North America, South America, the Far East) focusing on products with high added value.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report